Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-18-008513

EVP, R&D & Chief Scientific Of gave up 4,426 shares (to pay taxes)

  • EVP, R&D & Chief Scientific Of acquired 17,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Haqq Christopher EVP, R&D & Chief Scientific Of 2018-02-06 Grant or award +17,500 360,030 D
Haqq Christopher EVP, R&D & Chief Scientific Of 2018-02-06 Shares withheld for taxes −4,426 $35.80 $158,451 355,604 D
Derivatives
Haqq Christopher EVP, R&D & Chief Scientific Of 2018-02-06 Grant or award · Employee Stock Option (Right to Buy) +35,000 35,000 D
Loading xslF345X03/doc4.xml…